Ask AI
Bill115th CongressFiled Apr 24, 2017Health
S. 916

Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018

Bill journey · stage 1 of 5

Just introduced

Filed
Comm.
Floor
Both
Law

What it doesSummary reported to senate with amendment(s) (May 1, 2017)

Protecting Patient Access to Emergency Medications Act of 2017

(Sec. 2) This bill amends the Controlled Substances Act to direct the Drug Enforcement Administration (DEA) to register an emergency medical services (EMS) agency to administer controlled substances if the agency submits an application demonstrating that it is authorized to conduct such activity in the state in which the agency practices. The DEA may deny an application if it determines that the registration is inconsistent with the public interest.

An EMS agency may obtain a single registration in each state instead of a separate registration for each location.

A registered EMS agency may deliver, store, and receive controlled substances, subject to specified conditions.

An EMS professional of a registered EMS agency may administer controlled substances in schedules II, III, IV, or V outside the physical presence of a medical director if such administration is authorized under state law and pursuant to a standing or verbal order, subject to specified conditions.

The bill specifies that a hospital-based EMS agency (i.e., an EMS agency owned or operated by a hospital) may continue to administer controlled substances under the hospital's DEA registration.

(Sec. 3) A pharmacy may deliver a controlled substance to an administering practitioner in accordance with this bill's requirements, subject to specified conditions.

The Government Accountability Office must report to Congress on access to and the potential diversion of controlled substances administered by injection, implantation, or through the use of an intrathecal pump.

What just happenedMay 25, 2018

Held at the desk.

Who’s behind it

Sen. Cassidy, Bill [R-LA](R-LA)Sponsor
13 cosponsors7 D5 R1 I
Read on Congress.gov
13cosponsors1committees13actions2amendments3related bills5subjects
  1. May 25, 2018FloorH15000

    Held at the desk.

  2. May 25, 2018FloorH14000

    Received in the House.

  3. May 24, 2018Floor

    Message on Senate action sent to the House.

  4. May 23, 2018Floor

    Passed Senate with an amendment and an amendment to the Title by Unanimous Consent. (text: CR S2882-2884)

  5. May 23, 2018Floor17000

    Passed/agreed to in Senate: Passed Senate with an amendment and an amendment to the Title by Unanimous Consent.(text: CR S2882-2884)

  6. May 23, 2018Floor

    The committee substitute withdrawn by Unanimous Consent.

  7. May 23, 2018Floor

    Measure laid before Senate by unanimous consent. (consideration: CR S2882-2884)

  8. May 1, 2017Calendars

    Placed on Senate Legislative Calendar under General Orders. Calendar No. 46.

  9. May 1, 2017Committee

    Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.

    Health, Education, Labor, and Pensions Committee
  10. May 1, 2017Committee14000

    Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.

    Health, Education, Labor, and Pensions Committee
  11. Apr 26, 2017Committee

    Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.

    Health, Education, Labor, and Pensions Committee
  12. Apr 24, 2017IntroReferral

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Health, Education, Labor, and Pensions Committee
  13. Apr 24, 2017IntroReferral10000

    Introduced in Senate

Reported to Senate with amendment(s)May 1, 20171

Protecting Patient Access to Emergency Medications Act of 2017

(Sec. 2) This bill amends the Controlled Substances Act to direct the Drug Enforcement Administration (DEA) to register an emergency medical services (EMS) agency to administer controlled substances if the agency submits an application demonstrating that it is authorized to conduct such activity in the state in which the agency practices. The DEA may deny an application if it determines that the registration is inconsistent with the public interest.

An EMS agency may obtain a single registration in each state instead of a separate registration for each location.

A registered EMS agency may deliver, store, and receive controlled substances, subject to specified conditions.

An EMS professional of a registered EMS agency may administer controlled substances in schedules II, III, IV, or V outside the physical presence of a medical director if such administration is authorized under state law and pursuant to a standing or verbal order, subject to specified conditions.

The bill specifies that a hospital-based EMS agency (i.e., an EMS agency owned or operated by a hospital) may continue to administer controlled substances under the hospital's DEA registration.

(Sec. 3) A pharmacy may deliver a controlled substance to an administering practitioner in accordance with this bill's requirements, subject to specified conditions.

The Government Accountability Office must report to Congress on access to and the potential diversion of controlled substances administered by injection, implantation, or through the use of an intrathecal pump.

Introduced in SenateApr 24, 2017

Protecting Patient Access to Emergency Medications Act of 2017

This bill amends the Controlled Substances Act to direct the Drug Enforcement Administration (DEA) to register an emergency medical services (EMS) agency to administer controlled substances if the agency submits an application demonstrating that it is authorized to conduct such activity in the state in which the agency practices. The DEA may deny an application if it determines that the registration is inconsistent with the public interest.

An EMS agency may obtain a single registration in each state instead of a separate registration for each location.

A registered EMS agency may deliver, store, and receive controlled substances, subject to specified conditions.

An EMS professional of a registered EMS agency may administer controlled substances in schedules II, III, IV, or V outside the physical presence of a medical director if such administration is authorized under state law and pursuant to a standing or verbal order, subject to specified conditions.

The bill specifies that a hospital-based EMS agency (i.e., an EMS agency owned or operated by a hospital) may continue to administer controlled substances under the hospital's DEA registration.

A pharmacy may deliver a controlled substance to an administering practitioner in accordance with this bill's requirements, subject to specified conditions.

Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 — Informed